S

Soleno Therapeutics
D

SLNO

75.200
USD
0.19
(0.25%)
مغلق
حجم التداول
18,758
الربح لكل سهم
-3
العائد الربحي
-
P/E
-17
حجم السوق
3,753,104,386
أصول ذات صلة
ABBV
ABBV
5.160
(2.67%)
198.440 USD
ALNY
ALNY
3.98
(1.56%)
259.33 USD
C
CRMD
-0.25000
(-2.59%)
9.39000 USD
G
GLPG
0.583
(2.18%)
27.340 USD
GSK
GSK
-0.120
(-0.31%)
39.070 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
T
TTNP
-0.01000
(-0.27%)
3.75000 USD
المزيد
الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.